...
首页> 外文期刊>British Journal of Radiology >CT-MRI image fusion for delineation of volumes in three-dimensional conformal radiation therapy in the treatment of localized prostate cancer.
【24h】

CT-MRI image fusion for delineation of volumes in three-dimensional conformal radiation therapy in the treatment of localized prostate cancer.

机译:CT-MRI图像融合用于在局部保形性前列腺癌的三维保形放射治疗中确定体积。

获取原文
获取原文并翻译 | 示例
           

摘要

The objective of this study was to assess the utility of CT-MRI image fusion software and compare both prostate volume and localization with CT and MRI studies. We evaluated the differences in clinical volumes in patients undergoing three-dimensional conformal radiation therapy for localized prostate cancer. After several tests performed to ensure the quality of image fusion software, eight patients suffering from prostate adenocarcinoma were submitted to CT and MRI studies in the treatment position within an immobilization device before the start of radiotherapy. The clinical target volume (CTV) (prostate plus seminal vesicles) was delineated on CT and MRI studies and image fusion was obtained from the superimposition of anatomical fiducial markers. A comparison of dose-volume histograms relative to CTV, rectum, bladder and femoral heads was performed for both studies. Image fusion showed a mean overestimation of CTV of 34% with CT compared with MRI. Along the anterior-posterior and superior-inferior direction, CTV was a mean 5 mm larger with CT study compared with MRI. The dose-volume histograms resulting from CT and MRI comparison showed that it is possible to spare a mean 10% of rectal volume and approximately 5% of bladder and femoral heads, respectively. This study confirmed an overestimation of CTV with CT images compared with MRI. Because this finding only allows a minimal sparing of organs at risk, considering the organ motion during each radiotherapy session and the excellent outcomes of prostate cancer treatment with CT based target identification, we are still reluctant to reduce the CTV to that identified by MRI.
机译:这项研究的目的是评估CT-MRI图像融合软件的实用性,并将前列腺体积和定位与CT和MRI研究进行比较。我们评估了接受三维保形放射治疗的局部前列腺癌患者的临床量差异。为了确保图像融合软件的质量进行了几项测试之后,在放射治疗开始之前,对八名患有前列腺腺癌的患者在固定装置内的治疗位置进行了CT和MRI研究。在CT和MRI研究中勾画出了临床目标体积(CTV)(前列腺和精囊),并从解剖基准标记的叠加获得了图像融合。两项研究均比较了CTV,直肠,膀胱和股骨头的剂量-体积直方图。图像融合显示,与MRI相比,CT的CTV平均高估了34%。沿前后,上下方向,CT扫描显示的CTV平均比MRI大5毫米。通过CT和MRI比较得出的剂量-体积直方图显示,有可能分别平均节省10%的直肠体积和大约5%的膀胱和股骨头。这项研究证实,与MRI相比,CT图像对CTV的估计过高。考虑到每次放疗期间的器官运动以及基于CT靶标识别的前列腺癌治疗的出色结果,由于这一发现仅能使处于危险状态的器官最少地保留下来,因此我们仍然不愿意将CTV降低至MRI所鉴定的水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号